Biotech Company's Dramatic Turnaround
A CAR-T biotech company was acquired for over $3 billion after facing financial struggles three times. The company is working with a telehealth company called Prescribery.
Реклама: Article Inline
A CAR-T biotech company was acquired for over $3 billion after facing financial struggles three times. The company is working with a telehealth company called Prescribery.